ClassID:

20507

A61K31/688 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Phosphorus compounds; Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins

Recent Application in this class:
#1
20260151367
2026-06-04

KIT TO PROMOTE DEVELOPMENTAL MYELINATION

#2
20260132139
2026-05-14

HIV INHIBITOR COMPOUNDS

#3
20250339453
2025-11-06

NUTRITIONAL COMPOSITION FOR IMPROVING GUT MICROBIOTA

#4
20250312366
2025-10-09

CER-001 THERAPY FOR TREATING KIDNEY DISEASE

#5
20250312365
2025-10-09

METHODS FOR INHIBITION OF SQUAMOUS CARCINOMA CELLS USING CERAMIDE MODULATORS

#6
20250170061
2025-05-29

Treatment of Pneumonia

#7
20250109157
2025-04-03

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

#8
20250082656
2025-03-13

DOSAGE REGIMENS FOR TREATMENT OF DENGUE INFECTION

#9
20250049826
2025-02-13

COMPOSITION FOR PROMOTING THE MATURING OF THE CENTRAL NERVOUS SYSTEM

#10
20250042910
2025-02-06

HIV INHIBITOR COMPOUNDS

#11
20250025491
2025-01-23

USES OF COMPOSITIONS COMPRISING A PREBIOTIC COMPONENT

#12
20250000795
2025-01-02

TREATMENT OF SEPSIS AND SEPTIC SHOCK

#13
20240408121
2024-12-12

NUTRITIONAL COMPOSITION FOR IMPROVING SLEEP

#14
20240400589
2024-12-05

4-AMINOPHENYLPHOSPHORYLCHOLINE COMPOUNDS FOR BLOCKING C-REACTIVE PROTEIN

#15
20240383911
2024-11-21

AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF

#16
20240180962
2024-06-06

TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY

#17
20240180860
2024-06-06

NUTRITIONAL COMPOSITION FOR IMPROVING CELL MEMBRANES

#18
20240139120
2024-05-02

TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY

#19
20240024342
2024-01-25

MIV-818/LENVATINIB COMBINATION THERAPY FOR LIVER CANCER

#20
20240016824
2024-01-18

CER-001 THERAPY FOR TREATING KIDNEY DISEASE

#21
20240000717
2024-01-04

DRY POWDER ANTIVIRAL COMPOSITIONS AND THEIR USE FOR TREATING VIRAL INFECTION

#22
20230398211
2023-12-14

Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof

#23
20230398088
2023-12-14

Lipid Prophylactic Brain Injury Treatment

#24
20230285292
2023-09-14

COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM

#25
20230263179
2023-08-24

INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR

#26
20230226106
2023-07-20

A Novel formulation for rapid wound healing and control of infection

#27
20230210875
2023-07-06

LIPOSOMAL COMPOSITION FOR USE IN A METHOD OF TREATING PARKINSON'S DISEASE

#28
20230071393
2023-03-09

MATRIX BOUND VESICLES (MBV) FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME

#29
20230066517
2023-03-02

Phospholipid Ether Conjugates as Cancer-Targeting Drug Vehicles

#30
20230044738
2023-02-09

DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS

#31
20230041432
2023-02-09

COMPOSITIONS COMPRISING POLAR LIPIDS FOR MAINTAINING OR INCREASING MOBILITY AND VITALITY

#32
20230031648
2023-02-02

TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS

#33
20230027055
2023-01-26

HIV inhibitor compounds

#34
20220409641
2022-12-29

Phospholipid compositions

#35
20220387398
2022-12-08

IMMUNE TOLERIZATION AGENTS AND POTENTIATORS

#36
20220087934
2022-03-24

TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS

#37
20220023320
2022-01-27

Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of PAR-related diseases

#38
20210393655
2021-12-23

Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint

#39
20210322448
2021-10-21

CER-001 therapy for treating kidney disease

#40
20210290645
2021-09-23

Sting agonists for treating bladder cancer and solid tumors

#41
20210275452
2021-09-09

LIPOSOMES FOR INHIBITING BIOFILM FORMATION

#42
20210259967
2021-08-26

TREATMENT OF SEPSIS AND SEPTIC SHOCK

#43
20210170043
2021-06-10

DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS

#44
20210145741
2021-05-20

ANTIFIBROTIC COMPOSITION

#45
20210060041
2021-03-04

Sting agonists for treating bladder cancer and solid tumors

#46
20210030677
2021-02-04

Treatment of pneumonia

#47
20200360300
2020-11-19

Suppression of Cytokine Release and Cytokine Storm

#48
20200345639
2020-11-05

TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS

#49
20200230055
2020-07-23

LIPOSOMES FOR INHIBITING BIOFILM FORMATION

#50
20200121615
2020-04-23

Treating disease and promoting weight loss by inhibiting the TMA/FMO3/TMAO pathway

#51
20200046744
2020-02-13

Phospholipid compositions

#52
20190308983
2019-10-10

HIV inhibitor compounds

#53
20190254994
2019-08-22

Nutritional composition and infant formula for promoting myelination of the brain

#54
20190175629
2019-06-13

Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of PAR-related diseases

#55
20180360091
2018-12-20

NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN

#56
20180360090
2018-12-20

NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN

#57
20180352845
2018-12-13

NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN

#58
20180310605
2018-11-01

INFANT FORMULA WITH MILK FAT FOR PROMOTING HEALTHY GROWTH

#59
20180303856
2018-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#60
20180289728
2018-10-11

EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

#61
20180289709
2018-10-11

METHODS OF TREATING INFLAMMATION

#62
20180258097
2018-09-13

HIV inhibitor compounds

#63
20180186828
2018-07-05

Cyclic di-nucleotides as modulators of STING

#64
20180168215
2018-06-21

NUTRITIONAL COMPOSITIONS CONTAINING INOSITOL AND USES THEREOF

#65
20180153936
2018-06-07

COMPOSITIONS AND METHODS OF USING LAMELLAR BODIES FOR MODIFYING LINEAR BIOLOGICAL MACROMOLECULES

#66
20180133287
2018-05-17

NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC

#67
20180028598
2018-02-01

Compostions for Treating Dry Eye Disease

#68
20180028545
2018-02-01

PHOSPHOLIPID COMPOSITIONS

#69
20180021414
2018-01-25

METHODS OF REGULATING UPTAKE AND TRANSCELLULAR TRANSPORT OF LEUKOCYTES AND THERAPEUTICS

#70
20180000850
2018-01-04

Phospholipid compositions

#71
20170224711
2017-08-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#72
20170182121
2017-06-29

Charged lipoprotein complexes and their uses

#73
20170157166
2017-06-08

Solid ingestible composition comprising a fat globule membrane component and water-soluble dietary fiber

#74
20170131300
2017-05-11

Methods of identifying and quantifying sphingolipids

#75
20170128507
2017-05-11

Method of isolating sphingolipids from cordyceps and their use

#76
20170035788
2017-02-09

Vesicular Formulations

#77
20170007629
2017-01-12

Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid

#78
20160339043
2016-11-24

Compositions and methods for reducing intraocular pressure

#79
20160263132
2016-09-15

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#80
20160250260
2016-09-01

Small molecule cellular reprogramming to generate neuronal cells

#81
20160235809
2016-08-18

Compositions for treating dry eye disease

#82
20160175393
2016-06-23

USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID SPHINGOLIPID AND CHOLESTEROL

#83
20160101149
2016-04-14

Method for therapeutic replenishment and enrichment of ocular surface lubrication

#84
20160067295
2016-03-10

WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS

#85
20160015780
2016-01-21

Therapeutic modulation of ocular surface lubrication

#86
20150343027
2015-12-03

Hypotonic aqueous composition with reduced chloride content, with or without phospholipids

#87
20150342971
2015-12-03

Sphingomyelin-containing supplement

#88
20150265540
2015-09-24

INFANT NUTRITION WITH LIPID GLOBULES TO INCREASE ENERGY EXPENDITURE AND METABOLIC FLEXIBILITY LATER IN LIFE

#89
20150246065
2015-09-03

Topical Pharmaceutical Composition

#90
20150197527
2015-07-16

Compositions and methods for modulating TLR4

#91
20150157570
2015-06-11

Tailored liposomes for the treatment of bacterial infections

#92
20150065461
2015-03-05

Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint

#93
20150057249
2015-02-26

Vesicular formulations

#94
20140274956
2014-09-18

LIPIDOMICS OF FAMILIAL LONGEVITY

#95
20140206600
2014-07-24

Charged lipoprotein complexes and their uses

#96
20140199414
2014-07-17

KRILL AND/OR MARINE EXTRACTS FOR PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES, ARTHRITIS, SKIN CANCER, DIABETES, PREMENSTRUAL SYNDROME AND TRANSDERMAL TRANSPORT

#97
20140199265
2014-07-17

NUTRITIONAL COMPOSITIONS CONTAINING A NEUROLOGIC COMPONENT AND USES THEREOF

#98
20140100191
2014-04-10

Vesicular formulations

#99
20140093554
2014-04-03

NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE

#100
20140030366
2014-01-30

Method for treating neuronal damage and neurological diseases

#101
20130316980
2013-11-28

Hypotonic aqueous composition with reduced chloride content, with or without phospholipids

#102
20130280340
2013-10-24

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#103
20130225526
2013-08-29

Medicine, food and drink or feed containing sphingomyelin

#104
20130197038
2013-08-01

Compositions and methods for neovascularization

#105
20130157979
2013-06-20

Phosphate esters of gyrase and topoisomerase inhibitors

#106
20130095091
2013-04-18

Methods of regulating uptake and transcellular transport of leukocytes and therapeutics

#107
20130079307
2013-03-28

Medicine, food and drink or feed containing sphingomyelin

#108
20120309716
2012-12-06

Motor Function Improver

#109
20120270842
2012-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#110
20120245328
2012-09-27

Charged lipoprotein complexes and their uses

#111
20120232034
2012-09-13

VESICULAR FORMULATIONS

#112
20120208783
2012-08-16

Medicine, Food And Drink Or Feed Containing Sphingomyelin

#113
20120156133
2012-06-21

NON-RADIOACTIVE PHOSPHOLIPID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

#114
20120121757
2012-05-17

Infant nutritional compositions for preventing obesity

#115
20120053134
2012-03-01

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURONAL DAMAGE AND NEUROLOGICAL DISEASES

#116
20120021982
2012-01-26

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION

#117
20110305771
2011-12-15

Krill Extracts for Treatment of Cardiovascular Diseases

#118
20110300225
2011-12-08

Nutritional compositions with coated lipid globules

#119
20110300204
2011-12-08

NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE

#120
20110142908
2011-06-16

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

#121
20110136732
2011-06-09

INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY

#122
20110124606
2011-05-26

SENSE-IMPROVING AGENT

#123
20110098254
2011-04-28

COMPOSITIONS COMPRISING PHOSPHOLIPIDS

#124
20110092430
2011-04-21

METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE

#125
20110070222
2011-03-24

Therapeutic modulation of ocular surface lubrication

#126
20110065670
2011-03-17

Skin beautifier

#127
20110064661
2011-03-17

NON-RADIOACTIVE PHOSPHOLIPID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

#128
20110059902
2011-03-10

Compositions for treating dry eye disease

#129
20110045073
2011-02-24

METHODS AND COMPOSITIONS OF SPHINGOLIPID FOR PREVENTING AND TREATING MICROBIAL INFECTIONS

#130
20110034415
2011-02-10

WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS

#131
20110034407
2011-02-10

USE OF SPHINGOMYELIN AND NON-DIGESTIBLE CARBOHYDRATES FOR IMPROVING INTESTINAL MICROBIOTA

#132
20110009359
2011-01-13

USE OF NON-DIGESTIBLE CARBOHYDRATES FOR IMPROVING INTESTINAL MICROBIOTA

#133
20110003772
2011-01-06

USE OF SPHINGOLIPIDS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE AND METABOLIC SYNDROME

#134
20100048928
2010-02-25

Medicine, Food and Drink or Feed Containing Sphingomyelin

#135
20090203651
2009-08-13

USE OF SPHINGOLIPIDS IN THE TREATMENT AND PREVENTION OF TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE AND METABOLIC SYNDROME

#136
20090186808
2009-07-23

Method for the treatment of valvular disease

#137
20090186803
2009-07-23

USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.

#138
20090111773
2009-04-30

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#139
20080182902
2008-07-31

Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae

#140
20080085939
2008-04-10

Use Of Sphingolipids For Prevention And Treatment Of Atherosclerosis

#141
20080064664
2008-03-13

Skin Beautifier

#142
20070207983
2007-09-06

Use of Sphingolipids in the Treatment and Prevention of Type 2 Diabetes Mellitus, Insulin Resistance and Metabolic Syndrome

#143
20070157331
2007-07-05

Protection of female reproductive system from natural and artifical insults

#144
20070098808
2007-05-03

Krill extracts for treatment of cardiovascular diseases

#145
20060217312
2006-09-28

Charged lipoprotein complexes and their uses

#146
20060189575
2006-08-24

Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels

#147
20060134182
2006-06-22

Sphingolipids for improvement of the composition of the intestinal flora

#148
20060128666
2006-06-15

Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers

#149
20060078574
2006-04-13

Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

#150
20050070877
2005-03-31

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#151
20050064025
2005-03-24

Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers